Sat Kartar Life is a modern Ayurveda company that sells its own remedies straight to consumers, skipping shops and middlemen entirely. It started in 2012 as a product company built around a direct-to-consumer model, and in early 2026 rebranded from Sat Kartar Shopping to Sat Kartar Life - a signal that it is deliberately expanding from a single product engine into a full healthcare ecosystem spanning products, hospitals, nutraceuticals and spiritual wellness. The recurring approach is to take a traditional Ayurvedic remedy, validate it with modern data analytics, and then reach customers directly through digital platforms, television and call centres - using the consumer data that comes back to sharpen its marketing and develop the next product. # Business segments A single direct-to-consumer Ayurveda platform that is now deliberately branching into clinical care, nutraceuticals and spiritual wellness - each new line built on the same consumer database and digital infrastructure that powers the original product business. ## 1. Ayurvedic products and D2C platform: the engine that built the company **A portfolio of 160-plus proprietary Ayurvedic formulations sold directly to consumers through websites, television and marketplaces, supported by a 30-million-strong consumer database that feeds an AI-driven marketing flywheel.** - **Sold straight to the user, no middlemen** - the company operates a direct-to-consumer model through its own websites (satkartar.co.in and skinrange.com), third-party marketplaces like Amazon and Flipkart, television marketing on regional and DTH channels, and digital advertising across Google and Meta platforms, reaching customers in more than 10 languages and over 12,000 pincodes nationwide. - **Five remedies drive four-fifths of revenue** - the portfolio covers 16-plus therapeutic areas, but roughly 80% of product revenue comes from five core categories: Sexual Wellness, Diabetes, Piles Care, De-Addictions, and Bone & Joints; the remaining 20% spans PCOS/PCOD, respiratory support, hair care, liver care, infertility, mind care, immune support, lungs care and personal care. - **A database that makes marketing smarter** - the company holds a consumer database of over 30 million individuals and generates 25,000 daily unique leads, feeding a proprietary Lead Intelligence Engine that tracks behaviour and sharpens retargeting; AI deployment has delivered a 15-20% conversion uplift and lower cost-per-lead. - **Call centres close the sale** - four regional call centres across Tamil Nadu, Karnataka and the National Capital Region house over 750 multilingual advisors who provide personalised consultations in seven languages including Hindi, Kannada, Tamil, Telugu, Bengali, English and Malayalam, with proactive follow-up calls every 30 to 60 days that help drive a 25% repeat-customer rate. - **Half the capsules now made in-house** - the company originally outsourced all production to six third-party facilities; it now operates its own capsule manufacturing unit at Sonipat, Haryana, which will initially focus on manufacturing 50% of its capsule requirements, with the remaining half still co-functioning with the six external facilities. ## 2. Ayurveda hospitals and clinical care: the new physical front end **A 30-bed Ayurveda specialty hospital in Delhi that serves as a low-cost pilot for a planned nationwide chain, using an asset-light leased-facility model and a revenue-sharing partnership to expand into North and South India.** - **Low-cost beds, high therapy revenue** - the hospital was set up at roughly ₹7-8 lakh per bed using a leased-facility approach, and generates average revenue of ₹10,000 per bed per day from Panchkarma therapies, Kshar Sutra procedures for piles, kidney support therapies and in-house pharmacy sales. - **North India: paid for referrals** - under a three-year agreement with Jeena Sikho Lifecare, which operates roughly 2,800 beds in North India, Sat Kartar refers patient inquiries to Jeena Sikho’s clinical outlets and earns a revenue share of 15% of net billing value for OPD and medicine cases, and 15% of total bill value excluding GST and discounts for IPD and admissions. - **South India: own the hospitals** - in Tamil Nadu, Karnataka and Andhra Pradesh - Sat Kartar’s strongest markets - the company will open hospitals on its own balance sheet, owning the infrastructure and licensing, while Jeena Sikho may be engaged as the clinical operator for a management fee. - **A tiny share of a tiny market** - the company estimates the total organised Ayurveda hospital bed market in India at only 6,000-7,000 beds, with Jeena Sikho at about 2,800 beds and Sat Kartar currently at 30, giving it room to scale toward a planned 300 beds by end-2026 and eventually 1,000 beds. ## 3. Nutraceuticals and US operations: a parallel product track for a different customer **Lower-priced, high-repeat nutraceutical products sold under a separate brand and subsidiary structure, with a dedicated US subsidiary now operational in Texas.** - **Kept apart from the Ayurveda line** - the wholly-owned subsidiary Ajooni Life Sciences sells nutraceuticals under the “Vedabay” brand at ticket sizes of ₹900 to ₹1,200, deliberately separated from the core Ayurveda product range to avoid blurring the main brand. - **A diabetes brand with a 60% repeat rate** - the 100% subsidiary Plantomed Neutraceuticals focuses on diabetes-care nutraceuticals with low ticket sizes and high repeat consumption, and has already achieved a 60% repeat-customer rate; its product range is set and marketplace accounts are being readied for a US rollout. - **Live in the US from Texas** - the wholly-owned subsidiary Sat Kartar USA INC was acquired on 15 October 2025 and commenced commercial operations on 29 June 2026, with an office in Texas and a third-party logistics partner in New Jersey handling warehousing, inventory and order fulfilment for all US customer orders. ## 4. Spiritual offerings and wellness services: extending the platform into belief-based products **A newly adopted line of business that sells rudraksha beads, gemstones, puja items and spiritual consultations, using the same digital infrastructure and consumer reach that powers the Ayurveda platform.** - **Products and services under one roof** - the spiritual offerings business, formally adopted in May 2026, covers the manufacturing, trading and retailing of rudraksha beads, gemstones, idols, yantras, incense sticks, meditation accessories and spiritual books, alongside online and offline spiritual consultation, astrology consultation, meditation programmes and healing sessions. - **Content as a product** - the company also intends to publish books, journals, digital content and audiovisual material on spirituality, consciousness, mindfulness, astrology and personal transformation, and to collaborate with spiritual teachers, healers and practitioners. # Group structure and partners **A listed holding company with four subsidiaries arranged by product line and geography, plus a strategic hospital-referral partnership that splits the country into two operating models.** - Sat Kartar Life Limited (formerly Sat Kartar Shopping Limited) is the listed holding company, incorporated in 2012 and listed on NSE Emerge in January 2025, with its registered office in Delhi and operational facilities in Karnataka, Tamil Nadu and Maharashtra. - Plantomed Neutraceuticals Private Limited is a 100% subsidiary focused on diabetes-care nutraceuticals and US marketplace operations. - Sat Kartar USA INC is a 100% subsidiary incorporated in the US in August 2025, running commercial operations from Texas with fulfilment through a New Jersey logistics partner. - Sat Kartar Ocean Private Limited is an 81%-owned subsidiary incorporated in January 2026 to handle advertising, marketing, branding, media planning and digital marketing for the group. - The three-year non-exclusive agreement with Jeena Sikho Lifecare Limited splits the country: in North India, Sat Kartar earns a 15% revenue share on patient referrals to Jeena Sikho’s 2,800-bed network; in South India, Sat Kartar will open its own hospitals and may engage Jeena Sikho as the clinical operator for a management fee.